Nasdaq:US$16.68 (-0.98) | HKEX:HK$26.75 (+0.10) | AIM:£2.69 (-0.19)
上一篇文章   |   下一篇文章
公告及新聞稿, 監管通知 | 2018-03-19

Director’s Share Dealing

London: Monday, March 19, 2018: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has received notification that Dr Dan Eldar, Non-executive Director, purchased a total of 2,768 American Depositary Shares of the Company (“ADSs”, each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med) on March 14, 2018 at an average price of US$36.11 per ADS.

Following the above purchase, Dr Eldar is interested in 8,993 ADSs and 1,900 Ordinary Shares, representing approximately 0.0096% of the current issued share capital of Chi-Med.

Please download the full announcement for the notification as provided in accordance with the requirements of the EU Market Abuse Regulation.